Guru Baba Pharmax Private Limited

Molnupiravir is used to treat mild to moderate coronavirus disease 2019 (COVID-19) in non-hospitalized patients who are at high risk for progression to severe COVID-19 (eg, hospitalization, death) or in patients for whom other authorized or approved COVID-19 vaccines are not accessible or appropriate

Antiviral Drug Favipiravir is a broad-spectrum inhibitor of viral RNA polymerase, an enzyme required for viral replication when human host cells are infected. Favipiravir is effective in preventing viral transcription and replication of RNA polymerase. It is also used to treat Influenza and it has been investigated in other countries to treat novel viruses including Ebola and recently, COVID-19.